Michael Cecchini
Yale University
63 Papers
56 Citations
Michael Cecchini is an academic researcher from Yale University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 5, co-authored 25 publications. Previous affiliations of Michael Cecchini include Yale Cancer Center.
Chat about Author
Papers
Challenges with Novel Clinical Trial Designs: Master Protocols
Michael Cecchini,Eric H. Rubin,Gideon M. Blumenthal,Kassa Ayalew,Howard A. Burris,Michele Russell-Einhorn,Hildy Dillon,H. Kim Lyerly,Gregory H. Reaman,Scott A. Boerner,Patricia LoRusso +10 more
TL;DR: An in-depth discussion session to present “Challenges with Novel Clinical Trial Designs,” where assessments of the challenges faced by industry, the FDA, investigators, institutional review boards, and patients are offered.
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database
TL;DR: In this paper, the authors assess microsatellite and KRAS status, prevalence, and impact on outcome in stage IV colorectal cancer (CRC) using multivariable Cox proportional hazards models.
Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the US
Madhav Kc,Terry Hyslop,Sirad Salad Hassan,Michael Cecchini,Shi-Yi Wang,Andrea Silber,Michael S. Leapman,I. Leeds,Stephanie B. Wheeler,Lisa P. Spees,Cary P. Gross,Maryam B. Lustberg,Rachel A. Greenup,Amy C. Justice,Kevin C. Oeffinger,Michaela A. Dinan +15 more
TL;DR: In this paper , the relative burden of oncologic and non-oncologic mortality among long-term survivors of cancer in the US has been investigated in a cohort study of 627,702 patients surviving 5 years or more from an initial diagnosis of early-stage breast, prostate, or colorectal cancer.
14
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis.
Joseph A. Miccio,Wesley J. Talcott,Timil Patel,Henry S. Park,Michael Cecchini,Ronald R. Salem,Sajid A. Khan,Stacey Stein,Jeremy S. Kortmansky,Jill Lacy,Amol Narang,Joseph M. Herman,Salma K. Jabbour,Christopher L. Hallemeier,Kimberly L. Johung,Krishan R. Jethwa +15 more
TL;DR: This report studies neoadjuvant chemotherapy with or without radiation for pancreatic cancer and found the addition of radiation was associated with improved complete resection rates and improved pathologic down staging.
13
Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant
TL;DR: Two patients with metastatic melanoma who received treatment with immunotherapy after allogeneic stem cell transplantation that did not result in GVHD are reported.